Biotech startup IntelliProve has made headlines by securing a substantial €1.25M in seed funding. This innovative company is at the forefront of a groundbreaking technology that allows for “biopsies” to be conducted using nothing more than a smartphone camera.
Revolutionizing Healthcare with Technology
IntelliProve’s software is designed to measure crucial health parameters like heart rate, respiratory rate, and stress levels through optical face scans captured by a smartphone camera. This cutting-edge approach enables rapid and non-invasive health assessments, paving the way for enhanced preventive care.
The recent influx of funds came from various sources, including Belgian VC/Venture Studio Miles Ahead, Wit-Gele Kruis, imec.istart Fund, along with notable tech entrepreneurs such as Jeroen De Wit, Louis Jonckheere, Gilles Mattelin, Jorn Vanysacker, Matthias Geeroms, and Joris Van Der Gucht. Existing investors like The White and Yellow Cross and imec.istart fund also contributed to this round of financing.
Expanding Reach and Impact
With operations spanning across Belgium, The Netherlands, United Kingdom, Italy, France, Germany, and Denmark; IntelliProve’s client base includes prominent names like Helan and Neutraal Ziekenfonds Vlaanderen. By harnessing advanced signal processing and computer vision technologies on smartphones; the company offers what it refers to as “digital biopsies,” aimed at bolstering preventive healthcare measures.
Founded in 2021 through collaborations with organizations such as Het Wit-Gele Kruis, TU Delft, vzw Zorg-Saam; IntelliProve has established itself as a key player in the realm of medtech. Noteworthy certifications like CE-marking as a medical device and ISO27001 further validate the product’s credibility.
Visionaries in Preventive Healthcare
Joeri Tulkens—a co-founder and co-CEO at IntelliProve—expressed optimism about their trajectory stating: “This isn’t just a number; it represents millions of people benefiting from healthcare that is more accessible and personalized than ever before.” The company’s growth trajectory has been buoyed by strong support from research partners and investors alike.
Ad Brecht Dhuyvetters—co-founder and CPO—echoed this sentiment by emphasizing their commitment to creating an inclusive solution that enhances access to preventive healthcare services. With this recent injection of capital support; IntelliProve is poised to refine its offerings further while expanding its presence throughout Europe.
A Visionary Approach Recognized
Luc Burgelman—founder of Miles Ahead—commended IntelliProve’s unique position within the realm of preventive healthcare: “IntelliProve stands out with its strong team ethos coupled with an innovative approach towards healthcare.” The endorsement underscores the potential impact that this technological advancement may have on improving countless lives across various demographics.
Amidst accolades from industry leaders heralding their advancements in digital health solutions; IntelliProve remains steadfast in its mission to democratize access to cutting-edge healthcare technologies for all individuals.
In conclusion—IntelliProve’s commitment to innovation not only promises revolutionary changes within the healthcare landscape but also signifies a paradigm shift towards proactive wellness management leveraging state-of-the-art digital solutions.
